Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Eberl
Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab
Gastroenterologie a Hepatologie
Hepatology
Gastroenterology
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice
International Journal of Rheumatic Diseases
Rheumatology
Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Digestive Diseases and Sciences
Physiology
Gastroenterology
Does Infliximab Increase Complications After Surgery for Inflammatory Bowel Disease?
F1000 Medicine Reports
Health-Related Quality of Life of Patients With Inflammatory Bowel Disease in Singapore
Intestinal Research
Gastroenterology
Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Assessing Health-Related Quality of Life in Patients With Inflammatory Bowel Disease, in Crete, Greece
BMC Gastroenterology
Medicine
Gastroenterology
Efficacy of Adalimumab in Patients With Crohn's Disease and Failure to Infliximab Therapy: A Clinical Series
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
